Opportunities to improve the electronic reporting system for adverse drug reactions in Mexico: A comparative evaluation with the United States of America and the European Union
- PMID: 32838482
- DOI: 10.1002/pds.5092
Opportunities to improve the electronic reporting system for adverse drug reactions in Mexico: A comparative evaluation with the United States of America and the European Union
References
REFERENCES
-
- Food and Drug Administration, HHS. International Conference on Harmonisation; Electronic Transmission of Postmarket Individual Case Safety Reports for Drugs and Biologics, Excluding Vaccines; Availability of Food and Drug Administration Regional Implementation Specifications for ICH E2B(R3) Reporting to the Food and Drug Administration Adverse Event Reporting System. Notice of Availability. Fed Regist. 2016;81:40890-40891.
-
- EMA. History of EMA. European Medicines Agency 2018. Available at: https://www.ema.europa.eu/en/about-us/history-ema. Accessed July 31, 2020.
-
- Comisión Federal para la Protección contra Riesgos Sanitarios. NotiReporta. https://notireporta-cofepris.mx/. Accessed May 29, 2019.
-
- IHC Harmonised Tripartite Guideline. Maintenance of the ICH guideline on clinical safety data management: data elements for transmission of individual case safety reports E2B (R2). Current Step, 4. 2001. https://admin.ich.org/sites/default/files/inline-files/E2B_R2_Guideline.pdf.
-
- Food and Drug Administration. Adverse Events Reporting System (FAERS) Public Dashboard. https://fis.fda.gov/sense/app/d10be6bb-494e-4cd2-82e4-0135608ddc13/sheet.... Accessed June 26, 2020.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
